Anavex Life Sciences Appoints Terrie Kellmeyer as President and CEO
Anavex Life Sciences (AVXL) has officially appointed Terrie Kellmeyer as its new President and Chief Executive Officer. Kellmeyer, who previously served in the interim CEO role, will also take a seat on the company's Board of Directors. This leadership transition marks a move from interim management to permanent executive oversight for the biotechnology firm. The appointment is intended to provide stable leadership as the company continues its operations within the life sciences sector.
Tickers: $AVXL
Topics: Board of Directors CEO appointment Leadership change